Aspire Biopharma Holdings, Inc. Common Stock (ASBP) is a publicly traded Healthcare sector company. As of May 21, 2026, ASBP trades at $5.98 with a market cap of $8.09M and a P/E ratio of 0.00. ASBP moved +2.06% today. Year to date, ASBP is -95.82%; over the trailing twelve months it is -97.91%. Its 52-week range spans $3.31 to $11,832.00. Rallies surfaces ASBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ASBP financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ASBP recently traded at $5.98. Market cap is $8.09M. P/E ratio is 0.00. Revenue is $6.20K.
| Metric | Value |
|---|---|
| Price | $5.98 |
| Market Cap | $8.09M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.16% |
| 52-Week High | $11,832.00 |
| 52-Week Low | $3.31 |
| Volume | 3.57K |
| Avg Volume | 0 |
| Revenue (TTM) | $6.20K |
| Net Income | $-24.48M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $6.20K | $-24.48M | $0.00 |
ASBP analyst coverage data. Average price target: $0.00.